These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 437926)

  • 1. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-bound immunoglobulins. I. Further analysis of the characteristics of binding of immunoglobulins to in vivo-grown tumor cells.
    Dorval G; Witz IP; Klein E; Wigzell H
    Int J Cancer; 1976 Jan; 17(1):109-19. PubMed ID: 1248896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies.
    Ran M; Klein G; Witz IP
    Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor bound immunoglobulins: the relationship between the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, and the expression of immune complex receptors.
    Braslawsky G; Ran M; Witz IP
    Int J Cancer; 1976 Jul; 18(1):116-21. PubMed ID: 947858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on strain-dependent production of thymus-specific autoantibodies.
    Fuji H; Milgrom F
    J Exp Med; 1973 Jul; 138(1):16-32. PubMed ID: 4577617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin and other surface antigens of cells of the immune system.
    Takahashi T; Old LJ; McIntire KR; Boyse EA
    J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of cell-mediated cytotoxicity to a rat lymphoma. II. Characterization of the non-T cytotoxic cells stimulated in vivo by tumour cells as natural killer cells.
    Dawkins HJ; Shellam GR
    Int J Cancer; 1979 Aug; 24(2):244-52. PubMed ID: 314936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC; Baechtel FS; Goetz G; Prager MD
    Int J Cancer; 1977 May; 19(5):692-9. PubMed ID: 68017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-bound immunoglobulins: an in vivo phenomenon of masked specificity.
    Dorval G; Wilz IP; Klein E; Wigzell H
    J Natl Cancer Inst; 1976 Mar; 56(3):523-7. PubMed ID: 56447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.
    Wolf A; Steele KA; Alexander P
    Br J Cancer; 1976 Feb; 33(2):144-53. PubMed ID: 1259913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens.
    Grohmann U; Puccetti P; Fioretti MC; Mage MG; Romani L
    Int J Immunopharmacol; 1988; 10(7):803-9. PubMed ID: 3266198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.
    Farram E; Festenstein H; de Giorgi L
    Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-T-cell resistance against a mouse Moloney lymphoma.
    Kiessling R; Petrányi G; Klein G; Wigzell H
    Int J Cancer; 1976 Feb; 17(2):275-81. PubMed ID: 1082449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.